DR. MARK WALKER SMITH M.D. NPI 1396715843

NPI Details

DR. Mark Walker Smith, M.D. is a specialist in Sheffield, AL with 32 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Mark Walker Smith, M.D. NPI is 1396715843. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Graduation Year:1993

The provider's business location address is:

1015 S JACKSON HWY
SHEFFIELD, AL
ZIP 35660-760
Phone: (256) 381-5510
Fax: (256) 386-5551

The NPI 1396715843 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Urinalysis, manual test (HCPCS:81002)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Testosterone (hormone) level, total (HCPCS:84403)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 1/26/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: